Lapatinib (GW572016) is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively
Statement: 
->>Products covered by valid patents are not offered or supplied for commercial use. 
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1). 
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.


 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	            	  			       	
				         
	            	  			       	
				         
	            	  			       	
				         
	            	  			       	
				         
	            	  			       	
				         
	            	  			       	
				        